Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for “Active” Disease

• Ruoqi Peng ,

  Contributed equally to this work with: Ruoqi Peng, Sriram Sridhar

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Sriram Sridhar ,

  Contributed equally to this work with: Ruoqi Peng, Sriram Sridhar

  Affiliation Translational Research Sciences, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Gaurav Tyagi,

  Affiliation Non-Clinical Safety, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Jonathan E. Phillips,

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Rosario Garrido,

  Affiliation Non-Clinical Safety, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Paul Harris,

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Lisa Burns,

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Lorena Renteria,

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• John Woods,

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Leena Chen,

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• John Allard,

  Affiliation Translational Research Sciences, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Palanikumar Ravindran,

  Affiliation Translational Research Sciences, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Hans Bitter,

  Affiliation Translational Research Sciences, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Zhenmin Liang,

  Affiliation Non-Clinical Safety, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Cory M. Hogaboam,

  Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

  ⨯
• Chris Kitson,

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• David C. Budd,

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Jay S. Fine,

  Current address: Boehringer Ingleheim Pharmaceuticals, Ridgefield, Connecticut, United States of America

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
• Carla MT. Bauer,

  Affiliation DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America

  ⨯
•  [ ... ],
• Christopher S. Stevenson

  * E-mail: stevenson.cs@gmail.com

  Affiliations DTA Inflammation, Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, New Jersey, United States of America, Imperial College London, National Heart and Lung Institute, Centre for Respiratory Infections, Respiratory Pharmacology Group, Pharmacology and Toxicology Section, London, United Kingdom

  ⨯
• [ view all ]
• [ view less ]